- Report
- January 2026
- 258 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 196 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 307 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 154 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 183 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 182 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 277 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 369 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 110 Pages
Global
From €4123EUR$4,750USD£3,575GBP
- Report
- May 2025
- 115 Pages
Global
From €4123EUR$4,750USD£3,575GBP
- Report
- November 2025
- 150 Pages
Global
From €3255EUR$3,750USD£2,822GBP
- Report
- June 2025
- 150 Pages
Global
From €3255EUR$3,750USD£2,822GBP
- Report
- January 2026
- 130 Pages
Global
From €4123EUR$4,750USD£3,575GBP
- Report
- May 2025
- 100 Pages
Global
From €4123EUR$4,750USD£3,575GBP
- Report
- May 2025
- 140 Pages
Global
From €4123EUR$4,750USD£3,575GBP
- Report
- June 2025
- 400 Pages
Global
From €4296EUR$4,949USD£3,724GBP
- Report
- November 2025
- 146 Pages
Global
From €3429EUR$3,950USD£2,973GBP
- Report
- November 2025
- 148 Pages
Global
From €3429EUR$3,950USD£2,973GBP
- Report
- August 2025
- 171 Pages
Global
From €3124EUR$3,599USD£2,708GBP
- Report
- August 2025
- 150 Pages
Global
From €3124EUR$3,599USD£2,708GBP

The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more